Medical documentation services provider Augmedix Inc. (AUGX) entered a definitive merger agreement on July 19, 2024, with Commure, Inc. for a deal value of $139 million.
Under the terms of the agreement, Augmedix stockholders will receive $2.35 per share in cash, representing a premium of 156.44% from the stock’s last close.